Similar to a year ago, US equity markets contracted sharply in the first month of 2015. The Dow Jones Industrial Average, S&P 500 and NASDAQ fell 3.7%, 3.1% and 2.1% in January, respectively. While the markets recovered in 2014, equity prices in 2015 may face greater resistance, perhaps marking the end to the long equity […]
R&D spending rose an estimated 4.7% in fiscal year 2014 (ending March 31, 2014), the first increase since FY12, according to the results of a survey by Japan’s Ministry of Internal Affairs and Communications (MIC) published in December 2015 and a report compiled by the NSF’s Tokyo office released this month. The MIC survey of […]
Merck KGaA and Sigma-Aldrich Consolidation continued in the lab-products market, as less than a year after Thermo Fisher Scientific’s purchase of Life Technologies (see IBO 2/15/14), Merck KGaA announced a $17 billion deal to buy Sigma-Aldrich (see IBO 9/30/14). The deal highlights the importance of scale and diversification and transforms Merck/EMD Millipore into a major […]
San Diego, CA 1/12/15; San Francisco, CA 1/12/15; Washington, DC 1/12/15—At the annual JP Morgan Healthcare Conference, Illumina announced that its 2014 revenues grew 20%, following a 32% increase in the fourth quarter to $512 million. The company forecasts 2015 revenues to increase 20% and non-GAAP EPS of $3.12–$3.18. In addition, Illumina announced four new […]
The instrument industry performed well in 2014, a welcome rebound from a lackluster 2013. Although a fair degree of uncertainty reigned, a number of positive developments helped make the year a success. The most important development was the improvement of the US economy, which steadily accelerated. China also turned in good economic progress that was […]
Third quarter reported and organic revenues for IBO’s Lab Equipment/Consumables Sales Index grew 4.5% to $4,060 million. Operating profits rose at a similar pace, advancing 4.5% to $729 million. Based on continuing operations, operating margin expanded 10 basis points to 16.4% of sales. Kewaunee Scientific’s fiscal second quarter 2015 sales ending October 31 climbed 15.9% […]
Washington, DC 12/30/14—HTG Molecular Diagnostics has filed with the SEC for a public offering of its common stock on the NASDAQ stock exchange. No stock price or offering date was disclosed. The company provides the HTG Edge platform, consumables and software for facilitating complex molecular profiling for routine use in clinical and research applications. The […]
Although growing slower than in 2013, the US equity bull market continued to rally in 2014, capping a nearly six-year run. Spurred by loose monetary policy, sturdy corporate profits and improved economic data, the Dow Jones Industrial Average, S&P 500 and NASDAQ advanced 7.5%, 11.4% and 13.4%, respectively, in 2014. US equity markets withstood a […]
Signed into law on December 16, the US federal government’s fiscal 2015 (October 1, 2014–September 30, 2014) budget showed few major increases for R&D spending. The American Association for the Advancement of Science (AAAS) estimates that the total federal R&D budget increased just 1.7% to $137,611 million, with funding for nondefense R&D rising 1.6% to […]
Company Announcements PAC opened a technical facility in Shanghai, China’s pilot free-trade zone in October. The company also has a sales office in Shanghai. Third quarter organic sales for Danaher’s Life Science business grew in the low single digits, as positive demand in the US and Western Europe was hindered by funding delays in China. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
